Wen Ding

440 total citations
17 papers, 314 citations indexed

About

Wen Ding is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Wen Ding has authored 17 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Wen Ding's work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (3 papers) and Nanowire Synthesis and Applications (3 papers). Wen Ding is often cited by papers focused on CAR-T cell therapy research (8 papers), Virus-based gene therapy research (3 papers) and Nanowire Synthesis and Applications (3 papers). Wen Ding collaborates with scholars based in China, United States and Japan. Wen Ding's co-authors include Guangchao Li, Carlos Fernández‐Hernando, Rolando García-Milian, Yuting Liu, Alanna R. Kaplan, Yana K. Reshetnyak, Yajaira Suárez, Peter M. Glazer, Balkrishna Chaube and Sameet Mehta and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Wen Ding

17 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen Ding China	9	146	134	102	75	40	17	314
Zi‐Xun Yan China	10	140 1.0×	242 1.8×	64 0.6×	101 1.3×	33 0.8×	18	411
Jae Hun Shin United States	9	129 0.9×	151 1.1×	123 1.2×	39 0.5×	33 0.8×	14	342
Sergey Nechaev United States	7	155 1.1×	203 1.5×	189 1.9×	90 1.2×	21 0.5×	8	397
Tingyue Zhou China	9	118 0.8×	133 1.0×	126 1.2×	37 0.5×	34 0.8×	9	306
Joshua T. Eggold United States	6	109 0.7×	115 0.9×	53 0.5×	63 0.8×	18 0.5×	8	286
Xuewen Tan China	8	148 1.0×	177 1.3×	162 1.6×	66 0.9×	22 0.6×	9	399
Chen Hao Lo United States	10	167 1.1×	148 1.1×	132 1.3×	76 1.0×	15 0.4×	17	366
Steven Tsai United States	8	166 1.1×	151 1.1×	84 0.8×	20 0.3×	33 0.8×	14	308
L Danks United Kingdom	5	176 1.2×	213 1.6×	55 0.5×	43 0.6×	39 1.0×	7	379
Shuier Zheng China	13	144 1.0×	269 2.0×	94 0.9×	109 1.5×	19 0.5×	31	431

Countries citing papers authored by Wen Ding

Since Specialization

Citations

This map shows the geographic impact of Wen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Ding more than expected).

Fields of papers citing papers by Wen Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Ding. The network helps show where Wen Ding may publish in the future.

Co-authorship network of co-authors of Wen Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Ding. A scholar is included among the top collaborators of Wen Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Ding. Wen Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ding, Wen, Jianzheng Zhu, Jianshan Mo, et al.. (2025). Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer. Cancer Research. 85(22). 4469–4484. 2 indexed citations

Wang, Shuai, Zhengyang Chen, Bing Han, et al.. (2024). Advancing speaker embedding learning: Wespeaker toolkit for research and production. Speech Communication. 162. 103104–103104. 3 indexed citations

Wang, Jiaxi, Min Luo, Wenyi Lu, et al.. (2024). Phase I Clinical Trial of CD19 CAR-T Cells Expressing CXCR5 Protein for the Treatment of Relapsed or Refractory B-cell Lymphoma. Current Cancer Drug Targets. 25(9). 1170–1179. 1 indexed citations

Zhang, Hui, Guangchao Li, Wen Ding, et al.. (2022). Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis. Leukemia. 36(11). 2596–2604. 51 indexed citations

Hu, Gang, Guangchao Li, Wei Wen, et al.. (2022). Case report: B7-H3 CAR-T therapy partially controls tumor growth in a basal cell carcinoma patient. Frontiers in Oncology. 12. 956593–956593. 12 indexed citations

Hu, Gang, Yunsheng Liang, Guangchao Li, Wen Ding, & Min Luo. (2022). B7H3 CAR-T therapy in relation to tumor growth in skin tumor.. Journal of Clinical Oncology. 40(16_suppl). e21502–e21502. 2 indexed citations

Li, Guangchao, Qing Zhang, Zhi Liu, et al.. (2021). TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss. Cancer Cell International. 21(1). 223–223. 4 indexed citations

Li, Guangchao, Qing Zhang, Zeping Han, et al.. (2021). IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors. Frontiers in Oncology. 11. 734593–734593. 21 indexed citations

Li, Guangchao, Jintao Guo, Yanfang Zheng, et al.. (2021). CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells. Molecular Therapy — Oncolytics. 22. 507–517. 40 indexed citations

10.

Sahraei, Mahnaz, Balkrishna Chaube, Yuting Liu, et al.. (2019). Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. Journal of Clinical Investigation. 129(12). 5518–5536. 106 indexed citations

11.

Ding, Wen, Cheng Zhang, Xuedong Wu, et al.. (2018). Apoptosis of CD19+ chimeric antigen receptor T cells after treatment with chemotherapeutic agents. Molecular Medicine Reports. 18(1). 179–183. 1 indexed citations

12.

Wang, Tao, Sidong Yang, Sen Liu, et al.. (2016). 17β-Estradiol Inhibites Tumor Necrosis Factor-α Induced Apoptosis of Human Nucleus Pulposus Cells via the PI3K/Akt Pathway. Medical Science Monitor. 22. 4312–4322. 23 indexed citations

13.

Chen, Dan, Yingxi Li, Xiaodong Wang, et al.. (2015). Generation of regulatory dendritic cells after treatment with paeoniflorin. Immunologic Research. 64(4). 988–1000. 11 indexed citations

14.

Tao, Lei, Yong Shen, Wen Ding, et al.. (2014). Anterior Longitudinal Decompression in the Management of Severe Ossification of the Posterior Longitudinal Ligament in the Cervical Spine. Orthopedics. 37(5). e465–72. 5 indexed citations

15.

Y, Liu, et al.. (2013). Function of TGF-beta and p38 MAKP signaling pathway in osteoblast differentiation from rat adipose-derived stem cells.. PubMed. 17(12). 1611–9. 20 indexed citations

16.

Li, Qian, et al.. (2013). BMP-9 induces rabbit adipose-derived stem cells to differentiation into osteoblasts via BMP signaling pathway.. PubMed. 35(3). 171–7. 4 indexed citations

17.

Shen, Yong, et al.. (2012). Anterior Decompression in the Management of Unilateral Cervical Spondylotic Amyotrophy. Orthopedics. 35(12). e1792–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact